Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
Clinical trial NCT04257448 · COMPLETED
Trial details
- NCT number
- NCT04257448
- Sponsor
- GWT-TUD GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-25
- Primary completion
- 2024-07-02
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.